SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-133971
Filing Date
2022-04-29
Accepted
2022-04-29 16:32:57
Documents
12
Period of Report
2022-06-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d276398ddef14a.htm DEF 14A 377106
2 GRAPHIC g276398g22s22.jpg GRAPHIC 24810
3 GRAPHIC g276398g23s23.jpg GRAPHIC 16884
4 GRAPHIC g276398g24s24.jpg GRAPHIC 10015
5 GRAPHIC g276398g25s25.jpg GRAPHIC 9451
6 GRAPHIC g276398g26s26.jpg GRAPHIC 10637
7 GRAPHIC g276398g27s27.jpg GRAPHIC 10913
8 GRAPHIC g276398g28s28.jpg GRAPHIC 10390
9 GRAPHIC g276398g29s29.jpg GRAPHIC 10852
10 GRAPHIC g276398g30s30.jpg GRAPHIC 9324
11 GRAPHIC g276398g31s31.jpg GRAPHIC 9787
12 GRAPHIC g276398g32s32.jpg GRAPHIC 9052
  Complete submission text file 0001193125-22-133971.txt   558038
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39062 | Film No.: 22876238
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences